Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis
Clinical trial NCT03312751 · COMPLETED
Trial details
- NCT number
- NCT03312751
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2021-08-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.